Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BARI-PK: Rosuvastatin and Losartan Pharmacokinetics in Bariatric Surgery
NCT07748273Not yet recruiting
- Sponsor
- Hospital das Clínicas de Ribeirão Preto
- Start
- Aug 2026
- Primary completion
- May 2027
- Countries
- 1
01
Overview
Open-label trial of rosuvastatin and losartan (2 arms), sponsored by Hospital das Clínicas de Ribeirão Preto. Primary endpoints: Change in rosuvastatin area under the plasma concentration-time curve extrapolated to infinity and Change in losartan area under the plasma concentration-time curve extrapolated to infinity. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
rosuvastatinlosartan
Beyond the preview
Go deeper on NCT07748273.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07748273.